HopeStage
Back to all studies
RecruitingNCT05649059

Single-dose cannabidiol or placebo for social anxiety symptoms

About this titleRead the official source — NCT05649059
Medication studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

What will I do during this study?

You receive one oral dose of cannabidiol (Epidiolex) or placebo (an inactive comparison treatment). Researchers measure anxiety at several timepoints before and shortly after the dose, including 10, 20 and 30 minutes afterward.

Listed locations
CambridgeSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 10, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
50
Sponsor
Massachusetts Institute of Technology
Sponsor type
Research institute
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT05649059
Official title
Show the full official title

Investigating the Effects of Cannabidiol on Social Anxiety Disorder

Recruitment & locations

Currently recruiting

Cambridge

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts Institute of Technology, a research institute.

Does this study involve medication?

Yes. The study involves medication, including Cannabidiol and Placebo.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies